Yorke Justin W 4
4 · Processa Pharmaceuticals, Inc. · Filed Jul 28, 2025
Insider Transaction Report
Form 4
Yorke Justin W
Director
Transactions
- Award
Restricted Stock
2025-07-24+175,299→ 206,505 totalExercise: $0.00→ Common Stock (175,299 underlying)
Footnotes (2)
- [F1]Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 125,999 shares are subject to stockholder approval of the revised Omnibus Plan.
- [F2]The restricted stock vest on the earlier of June 30, 2026 or the next annual meeting of stockholders, subject to certain distribution requirements.